Small Pharma Archives

Psychedelics News

Small Pharma

Science

14 Jul 2022

Science Feature: Next-Generation Psychedelics

Next-generation psychedelics are compounds whose structure derives or is built upon classical psychedelics like DMT, LSD and psilocybin — yet changed by inserting modifications to reduce possible adverse effects....

By Elisabetta Fato

Industry

17 Jun 2022

Top Clinical Trials in 2022 (Part 2)

The success or failure of the sector’s advanced clinical trials will dictate the future of the industry....

By Jason Najum

Finance

15 Jun 2022

Small Pharma Gets Big Price Target From Two Analysts

Following this trend of confidence in mid-tier companies with good capital reserves, we have a string of positive coverage for Small Pharma....

By Jason Najum

Don’t Miss

13 Jun 2022

News You Might Have Missed: June 13th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Science

1 Jun 2022

A Deeper Look at DMT Trials & Studies

Preliminary results from Phase I clinical trials on DMT for major depressive disorder (MDD) support the safety and tolerability of the compound....

By Elisabetta Fato

Don’t Miss

30 May 2022

News You Might Have Missed: May 30th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

15 Mar 2022

Is the UK Becoming a Global Center for Psychedelic Medicine?

With innovative companies and industry-leading research, as well as an increasingly favorable regulatory environment, it seems the United Kingdom is indeed positioning itself as a leading center for the psychedelic...

By Freddie Earlam

Industry

10 Mar 2022

Small Pharma Expands Clinical Trial Pipeline

Lead DMT-assisted therapy candidate SPL026’s clinical development program strengthened with the addition of two clinical trials planned for 2022...

By Microdose

Finance

23 Feb 2022

A Look at Recent Financial and Business Highlights

To help keep you updated, we’ve put together a summary of recent financial announcements from a variety of psychedelic medicine companies....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result